3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
8
Active not recruiting
2
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Prostatic Neoplasms
9
Colorectal Neoplasms
5
Breast Neoplasms
5
Lung Neoplasms
4
Hematopoietic and Lymphatic System Neoplasm
2
Carcinoma, Non-Small-Cell Lung
2
Advanced Malignant Solid Neoplasm
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Spondylitis, Ankylosing
1
Sarcoma
1
Pyloric Stenosis, Hypertrophic
1
Psoriasis
1
Overweight
1
Ovarian Neoplasms
1
Obesity-Related Malignant Neoplasm
1
Obesity
1
Neoplasm Metastasis
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Lupus Erythematosus, Systemic
1
Inflammatory Bowel Diseases
1
Hematopoietic and Lymphoid System Neoplasm
1
Hematologic Neoplasms
1
Glioblastoma
1
Financial Stress
1
Esophageal Neoplasms
1
Crohn Disease
1
Interventions
Cyclophosphamide
27
fludarabine
18
Rituximab
17
obinutuzumab
11
venetoclax
9
Bendamustine Hydrochloride
9
Lenalidomide
8
zanubrutinib
6
Prednisone
6
Doxorubicin
6
Blood Specimen Collection
6
pembrolizumab
5
fludarabine phosphate
5
Biopsy
5
ibrutinib
4
glofitamab
4
Vincristine
4
Trimethoprim, Sulfamethoxazole Drug Combination
4
Exercise
4
loncastuximab tesirine
3
gamma-Globulins
3
axicabtagene ciloleucel
3
acalabrutinib
3
Temozolomide
3
Surveys and Questionnaires
3
Palliative Care
3
Mycophenolic Acid
3
Methotrexate
3
Mesna
3
Magnetic Resonance Spectroscopy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Lymphoma
×
Early Intervention, Educational
×
Clear all
NCT05006482
2026-01-13
GEM-S
University of Rochester
Phase 3
Recruiting
668 enrolled